BMEDS

Serial Number 90749761
606

Registration Progress

Application Filed
Jun 2, 2021
Under Examination
May 24, 2022
Approved for Publication
Mar 29, 2022
Published for Opposition
Mar 29, 2022
Registered

Attorney Assistance

Abandonment Notice E-Mailed - No Use Statement Filed
Due: Aug 30, 2025 49 days
Revival assistance for abandoned trademark

Trademark Image

BMEDS

Basic Information

Serial Number
90749761
Deadline
August 30, 2025
Description
Trademark Application Revival Due
Filing Date
June 2, 2021
Published for Opposition
March 29, 2022
Abandonment Date
June 30, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 30, 2025
Classes
009 042 044 045

Rights Holder

Bayesian Biotech LLC

16
Address
233 Mount Airy Road, Suite 100
Basking Ridge, NJ 07920

Ownership History

Bayesian Biotech LLC

Original Applicant
16
Basking Ridge, NJ

Bayesian Biotech LLC

Owner at Publication
16
Basking Ridge, NJ

Legal Representation

Attorney
Carole R. Klein

USPTO Deadlines

Next Deadline
49 days remaining
Abandonment Notice E-Mailed - No Use Statement Filed
Due Date
August 30, 2025

Application History

37 events
Date Code Type Description
Jun 30, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 30, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Feb 28, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 27, 2025 EX5G S SOU EXTENSION 5 GRANTED
Feb 27, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 19, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 19, 2024 EXT5 S SOU EXTENSION 5 FILED
May 15, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 14, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
May 14, 2024 EX4G S SOU EXTENSION 4 GRANTED
May 14, 2024 EXT4 S SOU EXTENSION 4 FILED
Nov 14, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 10, 2023 EX3G S SOU EXTENSION 3 GRANTED
Nov 10, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 10, 2023 EXT3 S SOU EXTENSION 3 FILED
May 16, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 12, 2023 EX2G S SOU EXTENSION 2 GRANTED
May 12, 2023 EXT2 S SOU EXTENSION 2 FILED
May 12, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 15, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 11, 2022 EX1G S SOU EXTENSION 1 GRANTED
Nov 11, 2022 EXT1 S SOU EXTENSION 1 FILED
Nov 11, 2022 EEXT I SOU TEAS EXTENSION RECEIVED
May 24, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 29, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 29, 2022 PUBO A PUBLISHED FOR OPPOSITION
Mar 9, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 23, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 20, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 19, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 19, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 12, 2022 CNRT R NON-FINAL ACTION WRITTEN
Jan 12, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 12, 2022 GNRT F NON-FINAL ACTION E-MAILED
Dec 16, 2021 DOCK D ASSIGNED TO EXAMINER
Aug 25, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 5, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 009
Downloadable computer software for use in calculating and tailoring the optimal individualized dosage for patients through blood samples from patients; downloadable computer software for use in mobile applications to develop model-informed precision dosing, track individualized dosing, generate population- and individual-based pharmacokinetic models, monitor clinical studies, determine optimal and lowest effective dosages of medication, develop risk evaluation and mitigation strategies and surveillance system for adverse effects, track status of government approval, and collect real world evidence on value of therapeutic agent
Class 042
Creating, maintaining and hosting an interactive website for others featuring technology that enables users to enter, access, track, and generate health and medical information; creating, maintaining and hosting an interactive website for others featuring technology that enables users to manage chronic diseases, medical conditions, and health risks; creating, maintaining, and hosting an interactive website for others featuring technology that enables users to enter medical information and generate the lowest effective dosage of medication; design and development of software in the field of interactive mobile applications featuring technology that enables users to manage their optimal dosing intervals of medication; Providing temporary use of nondownloadable computer software for use in calculating and tailoring the optimal individualized dosage for patients through blood samples from patients; Providing temporary use of non-downloadable computer software for use in mobile applications to develop model-informed precision dosing, track individualized dosing, generate population- and individual based pharmacokinetic models, monitor clinical studies, determine optimal and lowest effective dosages of medication, develop risk evaluation and mitigation strategies and surveillance system for adverse effects, track status of government approval, and collect real world evidence on value of therapeutic agent
Class 044
Providing an online database featuring medical information and diagnostics in the nature of pharmaceutical information for developing model-informed precision dosing, tracking individualized dosing, generating population based and individual based pharmacokinetic models, monitoring clinical studies, determining optimal and lowest effective dosages of medication, developing risk evaluation and mitigation strategies and surveillance system for adverse effects, and collecting real world evidence on value of therapeutic agent
Class 045
providing an online database featuring tracking the status of government approval of medications

Classification

International Classes
009 042 044 045